Table 5.
Entry No | Variety | Genotype using InDel and CAPS markers | Phenotype to differential isolates | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Z12F/R | 18729F3/R4-PvuII | PO6–6 | CA89 | BN209 | IK81–25 | M39–1–3-8-1 | M101–1–2-9-1 | BN111 | ||
IR64 | D | N | S | S | R | R | R | R | R | |
CO39 | I | Y | S | S | S | S | S | S | S | |
IRBLta2-Re [CO] | D | N | S | S | R | R | R | R | R | |
PR 1 | NSIC Rc 216 | I | N | S | R | R | R | R | R | S |
PR 2 | NSIC Rc 222 | I | N | S | R | R | R | R | R | S |
PR 3 | NSIC Rc 224 | D | N | R | R | R | R | R | R | R |
PR 4 | NSIC Rc 226 | I | N | S | R | R | R | R | R | S |
PR 5 | NSIC Rc 238 | D | N | R | R | R | R | R | R | R |
PR 6 | NSIC Rc 240 | D | N | S | R | R | R | R | R | R |
PR 7 | NSIC Rc 298 | I | N | S | S | R | R | R | R | S |
PR 8 | NSIC Rc 300 | I | d | S | S | R | R | S | S | S |
PR 9 | NSIC Rc 302 | I | N | S | S | S | R | R | S | R |
PR 10 | NSIC Rc 308 | I | N | S | S | R | R | R | R | S |
PR 11 | NSIC Rc 352 | I | N | S | S | R | R | R | R | S |
PR 12 | NSIC Rc 356 | D | N | R | R | R | R | R | R | R |
PR 13 | NSIC Rc 182 | I | N | S | R | R | R | R | R | S |
PR 14 | NSIC Rc 184 | I | N | S | S | S | R | R | S | S |
PR 15 | NSIC Rc 290 | D | N | S | S | R | R | R | R | R |
PR 16 | NSIC Rc 294 | I | N | S | S | R | R | R | R | S |
PR 17 | NSIC Rc 296 | I | N | S | S | R | R | R | R | S |
PR 18 | NSIC Rc 324 | I | N | S | S | R | R | R | R | S |
PR 19 | NSIC Rc 328 | D | N | R | R | R | R | R | R | R |
PR 20 | NSIC Rc 330 | I | N | S | R | R | R | R | R | R |
PR 21 | NSIC Rc 332 | D | N | S | R | R | R | R | R | R |
PR 22 | NSIC Rc 334 | I | N | R | S | R | R | R | R | S |
PR 23 | NSIC Rc 336 | I | N | S | S | R | R | R | R | R |
PR 24 | NSIC Rc 338 | D | N | S | S | R | R | R | R | R |
PR 25 | NSIC Rc 340 | I | d | S | S | R | R | R | R | R |
PR 26 | NSIC Rc 392 | D | N | S | S | R | R | R | R | R |
PR 27 | NSIC Rc 192 | I | d | R | S | S | R | S | S | R |
PR 28 | NSIC Rc 272 | I | N | R | S | R | R | R | R | R |
PR 29 | NSIC Rc 274 | I | N | R | R | R | R | R | R | R |
PR 30 | NSIC Rc 278 | D | N | S | S | R | R | R | R | R |
PR 31 | NSIC Rc 280 | I | d | S | S | R | R | R | S | S |
PR 32 | NSIC Rc 282 | D | N | S | S | R | R | R | R | R |
PR 33 | NSIC Rc 284 | I | N | S | S | R | R | R | R | S |
PR 34 | NSIC Rc 286 | I | N | S | S | R | R | R | R | S |
PR 35 | NSIC Rc 288 | I | d | S | S | R | S | S | S | R |
PR 36 | NSIC Rc 238 | D | N | R | R | R | R | R | R | R |
PR 37 | NSIC Rc 346 | I | N | S | S | R | R | S | R | R |
PR 38 | NSIC Rc 25 | I | N | R | R | R | R | S | R | R |
PR 39 | PSB Rc 18-Sub1 | D | N | S | S | R | R | R | R | R |
PR 40 | NSIC Rc 21SR | I | N | S | S | R | R | R | R | S |
PR 41 | NSIC Rc 218SR | I | N | S | R | R | R | R | S | S |
PR 42 | NSIC Rc 220SR | I | Y | R | R | R | R | R | R | R |
PR 43 | NSIC Rc 304SR | I | Y | R | R | R | S | R | S | R |
PR 44 | NSIC Rc 342SR | I | d | S | S | R | R | S | S | R |
PR 45 | NSIC Rc 344SR | D | N | S | S | R | R | R | R | R |
PR 46 | Mestiso 30 | I | N | R | S | R | R | R | R | S |
I: Amplicon size is 226 bp; D: Amplicon size is 214 bp; N: no cleavage site with PvuII and DNA fragment size is 812 bp; Y: containing cleavage site of PvuII and fragments’ sizes are 416 bp and 408 bp; d: containing a small deletion outside InDel region; R: resistant; S: susceptible; PO6–6 and CA89 are virulent isolates to Pita2 whereas other 5 isolates are avirulent